HEALTH CARE WARS:

JANUARY 2026 DASHBOARD

SECTION 1

THE IDEOLOGICAL THEATER

HHS Influencers' focus on "Big Food" and "Big Pharma" (X data)

Current month
Previous month
*New HHS Influencer
**Returning HHS Influencer

Notable new X followings

FDA Commissioner Marty Makary

  • Kristy Hawley:
    "Trauma Surgeon & Robotics Education Director" at the University of Colorado
  • Kris Newby:
    Author of Bitten: The Secret History of Lyme Disease and Biological Weapons
  • Dr. Mary Talley Bowden:
    Prominent vaccine critic; founder of Americans for Health Freedom (also followed by Director Bhattacharya)

NIH Director Jay Bhattacharya

  • Do No Harm:
    "Association of medical professionals combating the attack on our health care system from woke activists"
  • Jim Pethokoukis:
    Futurist and American Enterprise Institute senior fellow; recently authored articles on AI, genetics, and biohacking funding

Deputy HHS Secretary Jim O'Neill

  • Dr. Joseph Marine:
    Johns Hopkins cardiologist; praised MAHA report as chance to prioritize "cardiometabolic health"

HHS Senior Advisor Calley Means

  • Dan Go:
    Health transformation coach "helping entrepreneurs get lean and live longer"
  • Zach Lahn:
    Farmer and MAHA Action-endorsed Iowa governor candidate running on anti-"Big Ag and Big Pharma" platform

New Trump Administration hires and nominees

HireBackgroundPharma PerspectivesFood Perspectives
Tracy Beth Høeg,
Acting Director of the Center for Drug and Evaluation Research (CDER), FDA

Physician and prominent critic of government responses to COVID-19 who previously served as the Senior Advisor for Clinical Sciences to Commissioner Makary[1]

Published a November 2023 list of “FDA’s shortcomings” that critiqued FDA’s dependence on industry user fees, “revolving door” hiring, and “lack of transparency” while also asserting that the “media in the [United States] is beholden to the pharmaceutical industry”[2]

N/A

Martin Kulldorff,
Chief Science Officer for the Office of the Assistant Secretary for Planning and Evaluation (ASPE), HHS

Biostatistician, epidemiologist, and former Harvard Medical School professor who previously chaired CDC’s Advisory Committee on Immunization Practices (ACIP)[3]

Argued that “after the unscientific COVID-19 vaccine mandates, the only way to restore vaccine confidence is to let [Secretary Kennedy] do his proposed evidence-based vaccine studies"[4]

Stated that MAHA’s “key strength” is “its evidence-based multi-focus on the immune system, environment, mental health, nutrition, and exercise”[5]

Health care op-eds published in The New York Times, The Wall Street Journal, and The Washington Post


SECTION 2

THE COMMERCIAL THEATER

Top health care ad spenders on Meta Platforms

Corporate sponsors of health care conferences and "fly-ins"

National Comprehensive Cancer Network 2025 Patient Advocacy Summit (December 9)[6]

AbbVie, ADC Therapeutics, AstraZeneca, BeiGene, Boehringer Ingelheim, Bristol Myers Squibb, Cencora, Eisai, EMD Serono, Exact Sciences, Exelixis, Foundation Medicine, Genentech, Genmab, Gilead Sciences, GSK, Incyte, Johnson & Johnson, Lantheus, Lilly, Merck, Novartis, Pfizer, Regeneron, Sanofi, Servier, Sun Pharma, Taiho Oncology, and Takeda

American Society of Hematology 2025 Annual Meeting (December 12–15)[7]

AbbVie, AstraZeneca, GSK, Incyte Corporation, Lilly, Merck, and Novartis

Newsletter sponsors

Sponsorships
0510

Axios (Vitals)

1America's Health Insurance Plans
2Coalition to Strengthen America's Healthcare
3Humana
4Keep Americans Covered

Politico – Health Care
(Pulse and Prescription Pulse)

1Coalition to Strengthen America's Healthcare
2Optum
3Pharmaceutical Reform Alliance
4Evernorth Health Services
5Alvogen

Politico – Food/Ag
(Weekly Agriculture)

1Bayer
2Equifax

STAT News
(D.C. Diagnosis and
Morning Rounds)

1Novartis
2Merck
3GoodRx
4Johnson & Johnson
5Regeneron Genetics Center
  1. “Tracy Beth Høeg M.D., Ph.D.,” U.S. Food and Drug Administration, https://www.fda.gov/about-fda/fda-organization/tracy-hoeg.
  2. Tracy Beth Høeg, MD, PHD, “FDA’s shortcomings: A list,” Better than Fiction, Substack, November 15, 2023, https://tracybethhoegmdphd.substack.com/p/fdas-shortcomings-a-list.
  3. Press release, “Renowned Epidemiologist and Biostatistician Martin Kulldorff Appointed to Senior HHS Role,” U.S. Department of Health and Human Services, December 1, 2025, https://www.hhs.gov/press-room/renowned-epidemiologist-and-biostatistician-martin-kulldorff-appointed-to-senior-hhs-role.html.
  4. Martin Kulldorff [@MartinKulldorrff], “After the unscientific COVID vaccine mandates…,” X, January 27, 2025, https://x.com/MartinKulldorff/status/1883919904614895767.
  5. Martin Kulldorff [@MartinKulldorff], “The key strength of MAHA is…,” X, May 21, 2025, https://x.com/MartinKulldorff/status/1925240184372679014.
  6. "Patient Advocacy Summit," National Comprehensive Cancer Network, https://web.cvent.com/event/1b9b234d-5d36-483e-8696-762c0a63f9f1/summary.
  7. "ASH Annual Meeting and Exposition," American Society of Hematology, https://www.hematology.org/meetings/annual-meeting#about.

About Baron

Baron has guided clients for nearly two decades through the most challenging political terrain. Applying a methodology focused on mastering the strategic competition of interests, Baron advises some of the nation's most prominent organizations, including members of the Fortune 10, several of America's largest privately held businesses, and the U.S. Department of Defense. Baron's health care sector clients have included insurers and pharmacy benefit managers, integrated health systems, and medical device firms.


© 2026 Baron Public Affairs, LLC. All Rights Reserved. No part of these materials may be reproduced or transmitted in any form or by any means, electronic or mechanical, including but not limited to photocopy, recording, or any other information storage or retrieval system known now or in the future, without the express written permission of Baron Public Affairs, LLC. These materials do not constitute advice on any particular investment or commercial issue or matter. No part of this work constitutes investment or legal advice and is not to be relied upon as such. The unauthorized reproduction or distribution of this copyrighted work is illegal and may result in civil or criminal penalties under the U.S. Copyright Act and applicable copyright law.